Noticias de Eulerpool RemeGen Co

RemeGen Co Noticias de Acciones

RemeGen Co es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de RemeGen Co.

• 16 de junio ·

  Yahoo
  Asian Growth Stocks Insiders Own With Up To 32% Return On Equity
• 27 de mayo ·

  Yahoo
  RemeGen: Telitacicept for the Treatment of Generalized Myasthenia Gravis Approved in China
• 26 de mayo ·

  Yahoo
  3 Asian Stocks Estimated To Be Trading Below Intrinsic Value In May 2025
• 19 de mayo ·

  Yahoo
  3 Asian Growth Companies With Significant Insider Ownership
• 12 de mayo ·

  Yahoo
  Poised to Reshape Treatment Landscape: The Phase 3 Clinical Trial of Disitamab Vedotin as a First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic ‌Urothelial Carcinoma Reached its Primary Endpoints of PFS and OS
• 9 de mayo ·

  SeekingAlpha
  Biotech Outperformance - Can't Take What's Already Earned
• 2 de abril ·

  Yahoo
  3 Asian Stocks That May Be Trading Below Intrinsic Value By Up To 49%
• 20 de marzo ·

  Yahoo
  Asian Growth Companies With High Insider Ownership For March 2025
• 19 de febrero ·

  Yahoo
  3 Growth Companies With High Insider Ownership And 229% Earnings Growth
• 8 de enero ·

  Yahoo
  Published in Annals of Oncology: Disitamab Vedotin Combined with PD-1 Inhibitor is a Promising Treatment for Locally Advanced or Metastatic Urothelial Carcinoma